These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20689361)

  • 41. Costs of acute bacterial foodborne disease in Canada and the United States.
    Todd EC
    Int J Food Microbiol; 1989 Dec; 9(4):313-26. PubMed ID: 2701860
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Economic burden of injuries in South Korea.
    Lim SJ; Chung WJ; Cho WH
    Inj Prev; 2011 Oct; 17(5):291-6. PubMed ID: 21622932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of Latin American women.
    Schiola A; Lowin J; Lindemann M; Patel R; Endicott J
    Value Health; 2011; 14(5 Suppl 1):S93-5. PubMed ID: 21839909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic cost to New Zealand of foodborne infectious disease.
    Scott WG; Scott HM; Lake RJ; Baker MG
    N Z Med J; 2000 Jul; 113(1113):281-4. PubMed ID: 10935568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The socioeconomic burden of coronary heart disease in Korea.
    Chang HS; Kim HJ; Nam CM; Lim SJ; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2012 Sep; 45(5):291-300. PubMed ID: 23091654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Societal costs of multiple sclerosis in Ireland.
    Carney P; O'Boyle D; Larkin A; McGuigan C; O'Rourke K
    J Med Econ; 2018 May; 21(5):425-437. PubMed ID: 29320900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Evaluation of the burden of diabetes in Poland].
    Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Component costs of foodborne illness: a scoping review.
    McLinden T; Sargeant JM; Thomas MK; Papadopoulos A; Fazil A
    BMC Public Health; 2014 May; 14():509. PubMed ID: 24885154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calculating the economic burden of fatal drowning in Australia.
    Barnsley PD; Peden AE; Scarr J
    J Safety Res; 2018 Dec; 67():57-63. PubMed ID: 30553430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health care reform for Americans with severe mental illnesses: report of the National Advisory Mental Health Council.
    Am J Psychiatry; 1993 Oct; 150(10):1447-65. PubMed ID: 8379547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review of low back pain cost of illness studies in the United States and internationally.
    Dagenais S; Caro J; Haldeman S
    Spine J; 2008; 8(1):8-20. PubMed ID: 18164449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-of-Illness Trends Associated with Thyroid Disease in Korea.
    Hyun KR; Kang S; Lee S
    Endocrinol Metab (Seoul); 2014 Sep; 29(3):257-69. PubMed ID: 25309784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
    Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
    Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The economic burden of major adult visual disorders in the United States.
    Rein DB; Zhang P; Wirth KE; Lee PP; Hoerger TJ; McCall N; Klein R; Tielsch JM; Vijan S; Saaddine J
    Arch Ophthalmol; 2006 Dec; 124(12):1754-60. PubMed ID: 17159036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cost of liver disease in Korea: methodology, data, and evidence.
    Chung W
    Clin Mol Hepatol; 2015 Mar; 21(1):14-21. PubMed ID: 25834797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost measurement of mental disorders in Germany.
    Grupp H; Köenig HH; Konnopka A
    J Ment Health Policy Econ; 2014 Mar; 17(1):3-8. PubMed ID: 24864116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
    Sullivan PW; Follin SL; Nichol MB
    Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The excess cost of depression in South Australia: a population-based study.
    Hawthorne G; Cheok F; Goldney R; Fisher L
    Aust N Z J Psychiatry; 2003 Jun; 37(3):362-73. PubMed ID: 12780477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Smoking-attributable productivity loss in Germany--a partial sickness cost study based on the human capital potential method].
    Wegner C; Gutsch A; Hessel F; Wasem J
    Gesundheitswesen; 2004 Jul; 66(7):423-32. PubMed ID: 15314734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe.
    Hanly P; Soerjomataram I; Sharp L
    Int J Cancer; 2015 Feb; 136(4):E136-45. PubMed ID: 25066804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.